AN2 Therapeutics Q2 EPS $(0.81) Down From $(0.53) YoY
Portfolio Pulse from Benzinga Newsdesk
AN2 Therapeutics (NASDAQ:ANTX) reported Q2 losses of $(0.81) per share, a 52.83% decrease from $(0.53) per share in the same period last year.
August 10, 2023 | 9:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AN2 Therapeutics reported a 52.83% increase in losses per share YoY, which may negatively impact investor sentiment.
The increase in losses per share indicates that AN2 Therapeutics' financial performance has worsened compared to the same period last year. This could lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100